Sr. Principal Scientist
Spero Therapeutics
Disclosure: Spero Therapeutics (Employee, Shareholder)
Nicole Cotroneo, BS, is a Senior Principal Scientist at Spero Therapeutics, Inc., located in Cambridge Massachusetts. Nicole Cotroneo joined Spero Therapeutics as a biologist in 2015 where she focuses on preclinical characterization of new antibacterial agents. Prior to joining Spero, Nicole spent 18 years at Cubist Pharmaceuticals contributing to or leading a variety of early stage antibacterial discovery programs, such as target-based and natural products based discovery efforts, as well as the discovery of clinical stage novel polymyxin analog CB-182,804, and the Cubicin (daptomycin for injection) NDA. Prior to Cubist, Nicole entered the microbiology field as a research technician at the Boston University School of Medicine, studying nitrogen utilization in Bacillus subtilis. Nicole received a BS in biotechnology from the University of New Hampshire.
